Cardinal Health, Inc. is a global healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. We provide medical products and pharmaceuticals and cost-effective solutions that enhance the healthcare system and supply chain efficiency. Pharmaceutical and Specialty Solutions Segment In the United States, our Pharmaceutical and Specialty Solutions segment: ▪through its Pharmaceutical Distribution businesses: •distributes branded and generic pharmaceutical and over-the-counter healthcare and consumer products to retailers (including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers), hospitals, and other healthcare providers; ▪maintains prime vendor relationships that streamline the purchasing process, resulting in greater efficiency and lower costs for our retail, hospital, and other healt
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 244.7B | 222.6B | 226.8B | 205.0B | 181.4B | 162.5B |
| Net Income | 1.7B | 1.6B | 852M | 330M | -933M | 611M |
| EPS | $6.95 | $6.45 | $3.45 | $1.26 | $-3.35 | $2.08 |
| Free Cash Flow | 5.5B | 1.9B | 3.3B | 2.4B | 2.7B | 2.0B |
| ROIC | 146.6% | 3.5% | 2.0% | 1.0% | -1.1% | 43.0% |
| Gross Margin | 3.7% | 3.7% | 3.3% | 3.4% | 3.6% | 4.2% |
| Debt/Equity | 0.00 | -3.26 | -1.72 | -1.86 | -8.31 | 3.97 |
| Dividends/Share | $2.10 | $2.02 | $2.00 | $1.98 | $1.96 | $1.94 |
| Operating Income | 2.5B | 2.3B | 1.2B | 752M | -596M | 472M |
| Operating Margin | 1.0% | 1.0% | 0.5% | 0.4% | -0.3% | 0.3% |
| ROE | 0.0% | -52.1% | -26.5% | -11.2% | 131.6% | 34.1% |
| Shares Outstanding | 235M | 242M | 247M | 262M | 279M | 294M |
CARDINAL HEALTH INC passes 5 of 9 quality checks, suggesting mixed fundamentals.
CARDINAL HEALTH INC trades at 30.8x trailing earnings, compared to its 15-year median P/E of 25.1x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 9.2x vs a median of 7.5x. The company's 5-year average ROIC is 9.7% with a gross margin of 3.6%. Total shareholder yield (dividends + buybacks) is 3.2%. At current prices, the estimated annualized return to fair value is +9.3%.
CARDINAL HEALTH INC (CAH) has a current P/E ratio of 30.8, compared to its historical median P/E of 25.1. The stock is currently considered Fair based on its historical valuation range.
CARDINAL HEALTH INC (CAH) has a 5-year average return on invested capital (ROIC) of 9.7%. This is below average and may indicate limited pricing power.
CARDINAL HEALTH INC (CAH) has a market capitalization of $50.4B. It is classified as a large-cap stock.
Yes, CARDINAL HEALTH INC (CAH) pays a dividend with a trailing twelve-month yield of 0.98%. The company also returns capital through share buybacks, with a buyback yield of 2.25%.
Based on historical P/E analysis, CARDINAL HEALTH INC (CAH) appears fair. The current P/E of 30.8 is 23% above its historical median of 25.1. The estimated fair value CAGR (P/E method) is 11.3%.
CARDINAL HEALTH INC (CAH) operates in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry, within the Consumer Defensive sector.
CARDINAL HEALTH INC (CAH) reported annual revenue of $222.6 billion in its most recent fiscal year, based on SEC EDGAR filings.
CARDINAL HEALTH INC (CAH) has a net profit margin of 0.7%. This is a modest margin.
CARDINAL HEALTH INC (CAH) generated $1.9 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
CARDINAL HEALTH INC (CAH) reported earnings per share (EPS) of $6.45 in its most recent fiscal year.
CARDINAL HEALTH INC (CAH) has a return on equity (ROE) of -52.1%. A negative ROE may indicate losses or negative equity.
CARDINAL HEALTH INC (CAH) has a 5-year average gross margin of 3.6%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 18 years of financial data for CARDINAL HEALTH INC (CAH), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
CARDINAL HEALTH INC (CAH) has a book value per share of $-11.49, based on its most recent annual SEC filing.